Max Healthcare is due to list tomorrow (Friday, August 21) on the BSE (formerly Bombay Stock Exchange). HBI speaks to an operator source in Delhi to find out more.
Listed Romanian operator Medlife's H1 results partially reveal how the national lockdown affected its hospital, lab, dentistry, outpatient, pharmacy and corporate businesses. HBI analysis and investigation reveals the Q2 segment figures and the factors behind average price increases partially offseting sharp volume drops.
In the space of a week, Amazon has launched an online pharmacy pilot in India, the country's largest retailer has retaliated by buying a controlling stake in established rival Netmeds, and the market's other two largest players - PharmEasy and Medlife - have merged to create a $1.2bn+ valued company. This is despite ongoing legislation that might ban e-pharmacies from any activity at all.
Sweden's largest telehealth player KRY will be reimbursed in Germany after it received the necessary security accreditation. Meanwhile, Docly, the spin-off from Sweden's once largest player Min Doktor, has just withdrawn its healthcare services from its only international market following slow growth.
The IPO of international dialysis provider Diaverum by owner Bridgepoint is likely to have been pushed back to 2021, we are told. While dialysis volumes have been largely unaffected by the pandemic, lockdowns and travel restrictions may have hit its ability to reach full-year growth targets.
Polish symptom checker start-up Infermedica is looking to launch in Germany after a venture capital fund set up by the country's private insurers co-led its $10.5m Series A.
Biogroup, France's largest lab group by revenue, has new Belgian shareholders after it acquired family-owned CMA-Medina, its first move outside of the home market. CEO Stephane Eimer tells HBI that the new Franco-Belgian group will make more acquisitions there and abroad.
NHS England's exhaustive block-buying deal with the country's private hospitals will soon be replaced by a more local arrangement to help clear COVID-related backlogs of elective procedures, while smaller players are jostling to attack growing waiting lists for diagnostics. An advisor says the private sector is cutting corners when it comes to controlling COVID-19.
French medicalised homecare operator Sante Cie has acquired German operator Aposan just six months after being acquired by private equity firm Ardian. Aposan seller IK Investment has reportedly scored a 4x return on the deal.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
